Advertisement

Topics

JNJ To Pay Dearly For Talc-cancer Connection

18:23 EDT 21 Aug 2017 | FinanzNachrichten

NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) has been ordered to pay $417 million to a woman who claims to have developed ovarian cancer after using the company's talc products for feminine h...

Original Article: JNJ To Pay Dearly For Talc-cancer Connection

NEXT ARTICLE

More From BioPortfolio on "JNJ To Pay Dearly For Talc-cancer Connection"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Ovarian Cancer
Ovarian Cancer is cancer that starts in the female reproductive organs, the ovaries. It is the fifth most common cancer among women.  Women at risk of Ovarian Cancer are those who have had few children (or had children at an older age), carriers o...